Search Results - "Torffvit, O"

Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial) by Lind, Marcus, Hirsch, Irl B, Tuomilehto, Jaakko, Dahlqvist, Sofia, Ahrén, Bo, Torffvit, Ole, Attvall, Stig, Ekelund, Magnus, Filipsson, Karin, Tengmark, Bengt-Olov, Sjöberg, Stefan, Pehrsson, Nils-Gunnar

“…Study question What are the effects of liraglutide, an incretin based treatment, on glycaemic control in people with type 2 diabetes treated with multiple…”
Get full text

Willingness to pay for health improvements associated with anti-diabetes treatments for people with type 2 diabetes by Jendle, J., Torffvit, O., Ridderstråle, M., Lammert, M., Ericsson, Å., Bøgelund, M.

“…Abstract Objectives: This study aimed to investigate the most important consequences of diabetes medication, as measured by the patients’…”
Get full text

Willingness to pay for diabetes drug therapy in type 2 diabetes patients: based on LEAD clinical programme results by Jendle, J, Torffvit, O, Ridderstråle, M, Ericsson, Å, Nilsen, B, Bøgelund, M

“…The purpose of this study was to investigate the preferences of people with diabetes for liraglutide vs other glucose lowering drugs, based on outcomes of…”
Get more information

Nephropathy, but not retinopathy, is associated with the development of heart disease in Type 1 diabetes: a 12-year observation study of 462 patients by Torffvit, O., Lövestam-Adrian, M., Agardh, E., Agardh, C.-D.

“…Aims  To study the occurrence of heart disease and death in Type 1 diabetic patients and evaluate whether presence of microangiopathy, i.e. nephropathy and…”
Get full text

Serum cystatin C for assessment of glomerular filtration rate in pregnant and non-pregnant women. Indications of altered filtration process in pregnancy by Strevens, H., Wide-Swensson, D., Torffvit, O., Grubb, A.

“…Serum cystatin C is believed to reflect the glomerular filtration rate (GFR) more closely than serum creatinine in many contexts and a reference interval for…”
Get full text

Hyperglycaemia in diabetes: impact on nephropathy and cardiac risk by TORFFVIT, Ole

Get full text

Increased glomerular albumin permeability in old spontaneously hypertensive rats by Bakoush, Omran, Tencer, Jan, Torffvit, Ole, Tenstad, Olav, Skogvall, Ingela, Rippe, Bengt

“…Background. Severe long-standing hypertension is associated with an increased urinary protein excretion. Methods. To investigate the mechanisms of this…”
Get full text

Diabetic retinopathy, visual acuity, and medical risk indicators. A continuous 10-year follow-up study in Type 1 diabetic patients under routine care by Lövestam-Adrian, M, Agardh, C.-D, Torffvit, O, Agardh, E

“…The objective of this study was to describe incidence and progression of diabetic retinopathy in relation to medical risk indicators as well as visual acuity…”
Get full text

Effect of insulin on systemic and renal handling of albumin in nondiabetic and NIDDM subjects by Catalano, C., Muscelli, E., Quinones Galvan, A., Baldi, S., Masoni, A., Gibb, I., Torffvit, O., Seghieri, G., Ferrannini, E.

“…Effect of insulin on systemic and renal handling of albumin in nondiabetic and NIDDM subjects. C Catalano , E Muscelli , A Quiñones Galvan , S Baldi , A Masoni…”
Get full text

Renal structures in type 2 diabetic patients with elevated albumin excretion rate by ØSTERBY, R., TAPIA, J., NYBERG, G., TENCER, J., WILLNER, J., RIPPE, B., TORFFVIT, O.

“…Renal biopsies were obtained from type 2 diabetic patients with elevated albumin excretion. The aim was to obtain quantitative structural data to correlate…”
Get full text

Renal function in proteinuric glomerular diseases correlates to the changes in urine IgM excretion but not to the changes in the degree of albuminuria by Bakoush, O, Torffvit, O, Rippe, B, Tencer, J

“…Renal function in proteinuric glomerular diseases correlates to the changes in urine IgM but not to the changes in the degree of albuminuria. Albuminuria is…”
Get more information

Blockade of nitric oxide decreases the renal vasodilatory effect of neuropeptide Y in the insulin-treated diabetic rat by Torffvit, O, Edvinsson, L

“…The effect of 50 days of streptozotocine-induced diabetes mellitus (blood glucose 20 mmol/l) on contraction and relaxation of isolated renal and intrarenal…”
Get full text

Relaxing effect of insulin in renal arteries from diabetic rats by Torffvit, O, Edvinsson, L

“…Abnormal renal vasomotor tone exists in the early stages of diabetes mellitus. Insulin has been proposed to modulate renal function and to possess vasodilatory…”
Get full text

Is human insulin without effect in the diabetic rat? by Torffvit, O

Get full text

Early urinary changes in Tamm-Horsfall protein and epidermal growth factor in diabetic children by HOLMQUIST, Peter, TORFFVIT, Ole, JØRGENSEN, Per E, TØRRING, Niels, NEXØ, Ebba, SJÖBLAD, Sture

“…Both glomerular and tubular markers have been used to follow diabetic nephropathy. However, neither albumin nor proximal tubular markers have proven useful in…”
Get full text

A blood pressure cut-off level identified for renal failure, but not for macrovascular complications in type 2 diabetes: a 10-year observation study by Torffvit, Ole, Agardh, C-D

“…Can a cut-off blood pressure level for major complications be identified? A 10 years observation study in 385 type 2 diabetic patients. 158 patients were…”
Get more information

Tamm-Horsfall glycoprotein in streptozotocin diabetic rats : a study of kidney in situ hybridization, immunohistochemistry, and urinary excretion by RASCH, R, TORFFVIT, O, BACHMANN, S, JENSEN, P. K, JACOBSEN, N. O

“…Tamm-Horsfall glycoprotein, present only in the kidney thick ascending limb of Henle's loop, was studied here in streptozotocin diabetic rats. Tamm-Horsfall…”
Get full text

Urinary excretion of Tamm-Horsfall protein in normotensive, normo-albuminuric type 1 diabetic patients by Catalano, C, Torffvit, O

“…The excretion rate of a marker of distal tubular function, Tamm-Horsfall protein (THP), has been measured in urine (micrograms/min) overnight, during…”
Get more information

Glucagon-like peptide 1 (GLP-1) analogue combined with insulin reduces HbA1c and weight with low risk of hypoglycemia and high treatment satisfaction by Lind, Marcus, Jendle, Johan, Torffvit, Ole, Lager, Ibe

“…Abstract Aims To evaluate the effects of adding glucagon-like peptide-1 (GLP-1) analogue therapy to insulin on glycated hemoglobin (HbA1c), weight, insulin…”
Get full text

Decreased excretion of urine glycosaminoglycans as marker in renal amyloidosis by TENCER, J, TORFFVIT, O, GRUBB, A, BJÖRNSSON, S, THYSELL, H, RIPPE, B

“…The diagnosis of renal amyloidosis is normally established by kidney biopsy. In order to advance the determination of the diagnosis and the initiation of the…”
Get full text